Jupiter Neurosciences JUNS Cash Flow Statement (2023-2026)

NASDAQ JUNS
$1.82 -0.11 (-5.70%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Jupiter Neurosciences Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Jupiter Neurosciences reported cash from operations of -$2.29M and free cash flow of -$2.29M for the quarter ended Jun 2026, down 177.1% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -1.77M-0.43M-0.63M0.31M-0.59M-1.53M-1.53M-2.25M-2.29M-2.58M-2.06M-2.27M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.01M0.00M0.00M0.01M0.03M
Share-based CompensationStock Comp. 0.21M0.06M0.57M0.20M1.01M0.42M0.38M0.39M0.46M0.50M0.38M
Gains from Investment SecuritiesGains Investment -0.03M0.16M-0.04M-0.03M0.01M-1,282.00M1,281.45M
Other non-cash itemsOther Non-Cash 0.22M-1.78M-0.95M0.09M0.00M-0.55M
Change in Working Capital
Change in ReceivablesChange Receivables 0.00M0.01M
Change in InventoryChange Inventory -0.01M-0.01M
Change in Accrued ExpensesChange Accrued Exp. -0.04M0.02M0.02M0.08M-0.27M-0.11M0.29M-0.10M0.16M-0.16M0.44M
Change in TaxesChange Taxes -2.30M
Change in Other Operating AssetsOther Assets Change 174.00199.00343.00-0.02M0.14M0.02M0.04M-0.03M-0.03M0.03M0.00M
Change in Other Operating LiabilitiesOther Liabilities Change 0.24M0.18M0.18M0.18M-0.59M-0.01M0.45M0.00M-0.46M0.03M-0.01M
Other Working Capital ChangesOther WC Changes 0.24M0.18M0.18M0.20M-0.73M-0.03M0.41M0.03M-0.42M240.000.00M
Cash from OperationsCash from Ops. -0.16M-0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M-1.43M-2.29M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.13M0.05M0.06M0.03M0.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt 0.13M0.05M0.06M0.03M-0.15M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.13M0.05M0.06M0.03M-0.15M
Change in Capital Stock
Common Stock IssuedStock Issued 9.83M0.01M1.86M
Net Shares Issued and RepurchasedNet Shares Issued 9.83M0.01M1.86M
Net Equity Issued and RepurchasedNet Equity Issued 9.83M0.47M2.34M
Cash from Financing ActivitiesCash from Financing 0.13M0.05M0.11M0.03M7.47M0.01M1.45M
Additional items
Change in Cash -0.03M-0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M3.07M-1.43M-0.84M
Beginning Cash Balance 0.06M0.06M0.03M0.03M0.03M0.03M3.77M3.77M3.77M3.77M3.79M3.79M
Ending Cash Balance 0.06M0.03M0.01M0.01M253.003.77M2.71M1.88M0.72M3.79M2.36M1.52M
Free Cash FlowFCF -0.16M-0.07M-0.11M-0.04M-3.70M-1.06M-0.83M-1.15M-2.37M-1.43M-2.29M
Net Cash FlowNCF -0.03M-0.02M0.01M-0.01M3.77M-1.06M-0.83M-1.15M-2.37M-1.43M-0.84M
Interest Paid 0.03M0.03M0.09M146.0040.0085.000.04M0.12M0.10M

Jupiter Neurosciences Cash Flow Statement API

Pull Jupiter Neurosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=JUNS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY